- Home
- PKE vs ALDX Comparison
PKE vs ALDX Comparison
Compare PKE & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- ALDX
- Stock Information
- Founded
- PKE 1954
- ALDX 2004
- Country
- PKE United States
- ALDX United States
- Employees
- PKE N/A
- ALDX N/A
- Industry
- PKE Military/Government/Technical
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- ALDX Health Care
- Exchange
- PKE Nasdaq
- ALDX Nasdaq
- Market Cap
- PKE 378.7M
- ALDX 342.3M
- IPO Year
- PKE N/A
- ALDX 2014
- Fundamental
- Price
- PKE $19.03
- ALDX $4.96
- Analyst Decision
- PKE
- ALDX Strong Buy
- Analyst Count
- PKE 0
- ALDX 2
- Target Price
- PKE N/A
- ALDX $9.50
- AVG Volume (30 Days)
- PKE 90.6K
- ALDX 794.0K
- Earning Date
- PKE 10-14-2025
- ALDX 11-06-2025
- Dividend Yield
- PKE 2.60%
- ALDX N/A
- EPS Growth
- PKE 4.18
- ALDX N/A
- EPS
- PKE 0.34
- ALDX N/A
- Revenue
- PKE $63,456,000.00
- ALDX N/A
- Revenue This Year
- PKE N/A
- ALDX N/A
- Revenue Next Year
- PKE N/A
- ALDX $63.48
- P/E Ratio
- PKE $56.30
- ALDX N/A
- Revenue Growth
- PKE 16.60
- ALDX N/A
- 52 Week Low
- PKE $11.97
- ALDX $1.14
- 52 Week High
- PKE $20.73
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- PKE 56.32
- ALDX 34.88
- Support Level
- PKE $18.19
- ALDX $5.48
- Resistance Level
- PKE $19.31
- ALDX $5.88
- Average True Range (ATR)
- PKE 0.66
- ALDX 0.30
- MACD
- PKE -0.06
- ALDX -0.12
- Stochastic Oscillator
- PKE 58.98
- ALDX 1.62
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.